Resource Library




Featured Research / Clinical Immunology Research

Research published by VCCIS' members To find a publication quickly, use the "Search" feature and enter a keyword that may be found in the title of a publication. Click on the link or use the search command found in the footer of each webpage.
Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia
J.W. Swann, B. Szladovits, B. Glanemann, December 2015

  Immune-mediated hemolytic anemia (IMHA) is uncommon in cats, but may result in severe disease. Demographic predispositions for development of the disease and prognostic factors for mortality have not been investigated previously.

Subcategories:  Clinical Immunology Research
Development and implementation of a novel immune thrombocytopenia bleeding score for dogs
Kelly M. Makielski, Marjory B. Brooks, Chong Wang, Jonah N. Cullen, Annette M. O'Connor, Dana N. LeVine, April 2018

A method of quantifying clinical bleeding in dogs with immune thrombocytopenia (ITP) is needed because ITP patients have variable bleeding tendencies that inconsistently correlate with platelet count. A scoring system will facilitate patient comparisons and allow stratification based on bleeding severity in clinical trials.

Subcategories:  Clinical Immunology Research
Endothelial alterations in a canine model of immune thrombocytopenia
Dana N. LeVine, Rachel E. Cianciolo, Keith E. Linder, Petra Bizikova, Adam J. Birkenheuer, Marjory B. Brooks, Abdelghaffar K. Salous, Shila K. Nordone, Dwight A. Bellinger, Henry Marr, Sam L. Jones, Thomas H. Fischer, Yu Deng,Marshall Mazepa & Nigel S. Key, December 2015

Bleeding heterogeneity amongst patients with immune thrombocytopenia (ITP) is poorly understood. Platelets play a role in maintaining endothelial integrity, and variable thrombocytopenia-induced endothelial changes may influence bleeding severity. Platelet-derived endothelial stabilizers and markers of endothelial integrity in ITP are largely underexplored. We hypothesized that, in a canine ITP model, thrombocytopenia would lead to alterations in the endothelial ultrastructure and that the Von Willebrand factor (vWF) would serve as a marker of endothelial injury associated with thrombocytopenia. Thrombocytopenia was induced in healthy dogs with an antiplatelet antibody infusion; control dogs received an isotype control antibody. Cutaneous biopsies were obtained prior to thrombocytopenia induction, at platelet nadir, 24 hours after nadir, and on platelet recovery. Cutaneous capillaries were assessed by electron microscopy for vessel thickness, the number of pinocytotic vesicles, the number of large vacuoles, and the number of gaps between cells. Pinocytotic vesicles are thought to represent an endothelial membrane reserve that can be used for repair of damaged endothelial cells. Plasma samples were assessed for vWF. ITP dogs had significantly decreased pinocytotic vesicle numbers compared to control dogs (P = 0.0357) and the increase in plasma vWF from baseline to 24 hours correlated directly with the endothelial large vacuole score (R = 0.99103; P < 0.0001). This direct correlation between plasma vWF and the number of large vacuoles, representing the vesiculo-vacuolar organelle (VVO), a permeability structure, suggests that circulating vWF could serve as a biomarker for endothelial alterations and potentially a predictor of thrombocytopenic bleeding. Overall, our results indicate that endothelial damage occurs in the canine ITP model and variability in the degree of endothelial damage may account for differences in the bleeding phenotype among patients with ITP.

Subcategories:  Clinical Immunology Research
Systematic Review of Prognostic Factors for Mortality in Dogs with Immune-mediated Hemolytic Anemia
J.W. Swann, B.J. Skelly, January 2015

Treatment of dogs with primary immune-mediated hemolytic anemia (IMHA) is difficult and frequently unrewarding. Prognostic factors have been evaluated in a number of previous studies, and identification of such factors would be beneficial to enable selection of appropriate therapeutic regimens and supportive care.

Subcategories:  Clinical Immunology Research





Contact Us

VCCIS
44 W King St 1st Fl
Lancaster PA 17603-3809 USA
info@vccis.org

Connect With Us

© 2025 Veterinary & Comparative Clinical Immunology Society Inc. All rights reserved.
VCCIS is a 501(c)(3) nonprofit organization, EIN 85-2054415. Donations are tax-deductible.

Contact Us | Terms of Service | Privacy Policy | Security